MENU
RNAZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TransCode Therapeutics (RNAZ) Ownership - Who owns TransCode Therapeutics?
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer... Show more
Profile
Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
10
Web
https://www.transcodetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.84M
P/E Ratio
0.00
Total Cash
11.57M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.68
Dividend Yield
N/A
Total Cash/Share
13.88
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RNAZ
Capitalization
6.84M
P/E Ratio
0.00
Risk (Beta)
1.68
Dividend Yield
N/A
Total Cash
11.6M
Total Cash/Share
13.88
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
10.3M
P/B Ratio
0.66
Cash Flow
N/A
Earnings
-792.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.33K
Current Ratio
5.20
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-25.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-249.40
Shares Held By Institutions
915K
Shares Outstanding - Current
834K
Total Liabilities
2.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-91.299
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
10
Web
https://www.transcodetherapeutics.com